That likely only increases the appetite of biotech investors to bet on the next thing. But keep in mind the deal offers some ...

Pfizer was poised to seal a takeover of Metsera on Saturday after its improved offer won over the biotechnology startup's ...

Pfizer wins the $10B bid for Metsera, opening new avenues for obesity treatment and addressing unmet healthcare needs with ...

The Sickle Cell Disease Treatment Market offers significant opportunities with advancements in gene editing, stem cell therapies, and precision medicine driving innovation. Increased awareness and ...

Eli Lilly and Novo are preparing to announce new drug pricing deals with the White House, including for their blockbuster weight loss drugs. Blackstone Life Sciences will pay Merck $700 million for ...

Pfizer Inc. (NYSE:PFE) strengthens its global pharmaceutical leadership and research presence in the S&P 500 Index.

Pfizer Inc ( (PFE)) announced an update on their ongoing clinical study. Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to ...

Pfizer Inc. ( PFE) Discusses Clinical Development Strategy for 4404 Bispecific Antibody in Oncology November 10, 2025 8:30 AM EST ...

On Thursday, the U.S. Food and Drug Administration (FDA) began to alert patients, caregivers and healthcare professionals about Pfizer’s voluntary withdrawal of OXBRYTA. The withdrawal comes after ...

President Donald Trump’s new partnership with Pfizer to sell drugs directly to consumers is being cast as a major ...

The greater a company's earnings, the better its position will be to pay dividends. However, Pfizer's adjusted earnings per share (EPS) declined 18% year over year in Q3. That might seem to indicate ...

Tragedy has struck during an important Pfizer medical trial, when a young boy suffered a fatal sudden cardiac arrest after receiving experimental gene therapy — a death that’s sent scientists and ...